Thompson Siegel & Walmsley’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-56,100	Closed	-$108K	–	575
2022 Q3	$108K	Hold	56,100	–	–	﹤0.01%	387
2022 Q2	$209K	Buy	56,100 +14,000	+33%	+$52.2K	﹤0.01%	341
2022 Q1	$274K	Buy	+42,100	New	+$274K	﹤0.01%	348